ArticleNon-coding RNA research2021
A holistic miRNA-mRNA module discovery.
Article in Non-coding RNA research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Single-Cell Sequencing Combined with Transcriptome Sequencing Constructs a Predictive Model of Key Genes in Multiple Sclerosis and Explores Molecular Mechanisms Related to Cellular Communication.Journal of inflammation research · 2024Article
- How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development.Frontiers in immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The regulatory role of the Micro-RNAs (miRNAs) in the messenger RNAs (mRNAs) gene expression is well understood by the biologists since some decades, even though the delving into specific aspects is in progress. In this paper we will focus on miRNA-mRNA modules, where regulation jointly occurs in miRNA-mRNA pairs. Namely, we propose a holistic procedure to identify miRNA-mRNA modules within a population of candidate pairs. Since current methods still leave open issues, we adopt the strategy of postponing any decision on the value of the module ingredients exactly at the end, i.e. at the moment of biologically exploiting the results. This diverts chains of statistical tests into sequences of specially-devised-evolving metrics on the possible solutions. This strategy is rather expensive under a computational perspective, so needing implementations on HPC. The reward stands in the discovery of new modules, possibly hosting non differentially expressed miRNAs and mRNAs and pairs containing genes that currently are considered not targeted. In the paper we implement the procedure on a Multiple Myeloma dataset publicly available on GEO platform, as a template of a cancer instance analysis, and hazard some biological issues. These results, jointly with the normal manageability of the computations, suggest that the discovery procedure may be profitably extended to a wide spectrum of diseases where miRNA-mRNA interactions play a relevant role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.